Breztri Aerosphere (budesonide/glycopyrronium/ formeterol fumarate dihydrate)

pCPA File Number: 21595
Negotiation Status:
Concluded with an LOI
Indication(s):
Chronic Obstructive Pulmonary Disease (COPD)
Sponsor/Manufacturer:
AstraZeneca Canada Inc.
CDA-AMC Project Number:
SR0675-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: